Back to User profile » Dr Guido Nador
Papers published by Dr Guido Nador:
Original Research
Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST Study
Yoshihara S, Meche A, Hlavacek P, Johnson SM, Demers AS, Nador G, Ikoma S, Yadav CP, Assaf CA, DiBonaventura M, Chen Y
ClinicoEconomics and Outcomes Research 2026, 18:581258
Published Date: 11 March 2026
Short Report
An Updated Indirect Comparison of Elranatamab Versus a Real-World External Control Arm in Triple-Class Refractory Multiple Myeloma
Costa LJ, LeBlanc TW, Tesch H, Sonneveld P, Johnson SM, Vekeman F, Hlavacek P, Meche A, Kim CH, Cislo P, Hughes DM, Nador G, DiBonaventura M
Blood and Lymphatic Cancer: Targets and Therapy 2025, 15:11-20
Published Date: 5 June 2025
Short Report
Matching-Adjusted Indirect Comparison of Elranatamab versus Teclistamab in Patients with Triple-Class Exposed/Refractory Multiple Myeloma: Updated Results
Mol I, Hu Y, LeBlanc TW, Cappelleri JC, Chu H, Nador G, Aydin D, Perez Cruz I, Hlavacek P
Journal of Blood Medicine 2025, 16:233-239
Published Date: 14 May 2025